BERAPROST

INDICATION AND DOSAGE OF BERAPROST

 

Introduction

Beraprost is a synthetic prostacyclin analogue with pharmacological properties that make it a valuable therapeutic agent in certain medical conditions. As a prostacyclin analog, it is designed to mimic the effects of prostacyclin, a naturally occurring prostaglandin with vasodilatory and anti-platelet aggregation properties. This essay delves into the specifics of Beraprost, including its dosage forms and strengths, brand and generic names, indications for use, mechanism of action, administration and dosage, side effects and precautions, and concludes with a summary of its clinical relevance.

Dosage Forms and Strengths

Beraprost is available in oral tablet form, which allows for convenient administration. The tablets typically come in strengths of 20 micrograms (mcg), although the exact strength may vary depending on the manufacturer and the market.

Brand and Generic Names

The primary brand name for Beraprost is Beraprost Sodium, which may be marketed under different names in various regions. Its generic name is Beraprost, reflecting its status as a synthetic prostacyclin analogue. In some countries, Beraprost may be available under other brand names, reflecting regional market preferences.

Indications for Use

Beraprost is primarily indicated for the treatment of conditions related to impaired blood flow and vascular dysfunction. Its most common uses include:

  1. Peripheral Arterial Disease (PAD): Beraprost is used to alleviate symptoms of intermittent claudication associated with PAD. It improves walking distance and reduces pain during physical exertion by enhancing blood flow to the extremities.

  2. Pulmonary Arterial Hypertension (PAH): In some cases, Beraprost is used as part of the treatment regimen for PAH to help manage elevated blood pressure in the pulmonary arteries and improve exercise capacity.

Mechanism of Action

Beraprost functions by mimicking the effects of prostacyclin, which is a potent vasodilator and inhibitor of platelet aggregation. Its primary mechanism of action involves:

  1. Vasodilation: Beraprost relaxes the smooth muscles of blood vessels, leading to vasodilation and improved blood flow. This helps reduce the resistance in peripheral and pulmonary arteries.

  2. Anti-Platelet Aggregation: By inhibiting the aggregation of platelets, Beraprost reduces the likelihood of clot formation, which can improve blood flow and reduce the risk of cardiovascular events.

Administration and Dosage

Beraprost is administered orally, and the dosage can vary based on the condition being treated and patient-specific factors. Typically, the recommended dosage for intermittent claudication is one 20 mcg tablet taken three to four times daily. For pulmonary arterial hypertension, dosages may be adjusted based on clinical response and tolerance. It is important for patients to follow their healthcare provider's instructions regarding dosage and frequency to achieve optimal therapeutic outcomes.

Side Effects and Precautions

Like all medications, Beraprost can cause side effects. Common side effects may include:

  1. Headache: A frequent side effect that may diminish over time.
  2. Flushing: Sensation of warmth and redness in the skin due to vasodilation.
  3. Gastrointestinal Symptoms: Nausea, diarrhea, and abdominal pain.

Serious side effects are rare but can include:

  1. Hypotension: Significant lowering of blood pressure that could lead to dizziness or fainting.
  2. Bleeding: Increased risk of bleeding due to its anti-platelet effects.

Patients should be cautious if they have a history of bleeding disorders or low blood pressure. Regular monitoring by healthcare professionals is recommended to manage and mitigate potential risks.

Conclusion

Beraprost, as a synthetic prostacyclin analogue, offers a significant therapeutic advantage in the management of peripheral arterial disease and pulmonary arterial hypertension. Its ability to enhance blood flow and reduce platelet aggregation makes it an effective treatment option for these conditions. However, like all medications, it is essential to be aware of potential side effects and adhere to prescribed dosages. Through careful management and monitoring, Beraprost can play a crucial role in improving patient outcomes in vascular diseases.

INDICATION AND DOSAGE OF BERAPROST

Sort By:  
BERAPROST FILM-COAT TB 0.2 MG 10 UNITS DORNER ASTELLAS PHARMA (excluded of 20 USD Postage fee/order)
Beraprost has been studied for the treatment of pulmonary hypertension, Buerger's disease, arteriosclerosis obliterans, and for use in avoiding reperfusion injury.
12.63 USD

BERAPROST FILM-COAT TB 0.2 MG 10 UNITS DORNER ASTELLAS PHARMA (excluded of 20 USD Postage fee/order) (DORNER)

Beraprost has been studied for the treatment of pulmonary hypertension, Buerger's disease, arteriosclerosis obliterans, and for use in avoiding reperfusion injury.
12.63 USD

GTM

Jinimed © 2025Powered By  AbanteCart